India approves emergency use of remdesivir to treat COVID-19 patients
By Administrator_India Capital Sands India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients. Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials and is at the forefront of […]